// company-profile

Corvus Pharmaceuticals, Inc.

CRVSExchange: NasdaqSector: Pharmaceutical PreparationsInc.: DEFilings: 40Insiders: 15

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Chan Andrew C..

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Apr 23, 2026Chan Andrew C.CRVSAward30,000$0.00$0K
Jan 28, 2026Thompson Peter A.CRVSOption Exercise15,000$9.70$146K
Jan 28, 2026Thompson Peter A.CRVSOption Exercise15,000$12.50$188K
Jan 28, 2026Thompson Peter A.CRVSOption Exercise15,000$3.61$54K
Jan 28, 2026Thompson Peter A.CRVSOption Exercise15,000$2.00$30K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →